HCW Biologics (HCWB) Other Non-Current Liabilities (2022 - 2025)

HCW Biologics (HCWB) has 3 years of Other Non-Current Liabilities data on file, last reported at $692531.0 in Q4 2025.

• Quarterly Other Non-Current Liabilities changed N/A year-over-year to $692531.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $692531.0 (changed N/A YoY) and the FY2025 annual result came in at $692531.0, changed N/A from the prior year.
• Other Non-Current Liabilities held at $692531.0 in Q4 2025, from $692531.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $1.7 million in Q2 2025 to a low of $7476.0 in Q1 2023.
• A 3-year average of $352403.3 and a median of $83473.5 in 2022 frame the typical range for Other Non-Current Liabilities.
• The widest YoY moves for Other Non-Current Liabilities: up 379.86% in 2023, down 94.64% in 2023.
• Tracing HCWB's Other Non-Current Liabilities over 3 years: stood at $14275.0 in 2022, then soared by 379.86% to $68500.0 in 2023, then soared by 910.99% to $692531.0 in 2025.
• The last three Other Non-Current Liabilities figures came in at $692531.0 (Q4 2025), $692531.0 (Q3 2025), and $1.7 million (Q2 2025), per Business Quant data.